A forte demanda global j provocou momentos de escassez em diferentes mercados, exigindo ajustes na cadeia de produo e distribuio
A healthcare professional will conduct a comprehensive evaluation to ensure the treatment is safe and appropriate for your unique health status
A new study in Exploration of Neuroprotective Therapy proposes a fundamental reconceptualisation of post-stress depressive pathogenesis
Novo Nordisk's patent for Saxenda expires later this year, and rivals Teva, Pfizer and Mylan are all expected to launch generic versions of liraglutide later in 2024
Ask specifically: what are your coverage criteria for Wegovy, Zepbound, or whatever GLP-1 medication you are pursuing
The loss of muscle mass is particularly relevant for patients with metabolic diseases and older people, for whom muscle mass loss expedites sarcopenia development